Correlation Between Cardiff Oncology and Navidea Biopharmaceutica
Can any of the company-specific risk be diversified away by investing in both Cardiff Oncology and Navidea Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardiff Oncology and Navidea Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardiff Oncology and Navidea Biopharmaceuticals, you can compare the effects of market volatilities on Cardiff Oncology and Navidea Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardiff Oncology with a short position of Navidea Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardiff Oncology and Navidea Biopharmaceutica.
Diversification Opportunities for Cardiff Oncology and Navidea Biopharmaceutica
-0.41 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Cardiff and Navidea is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Cardiff Oncology and Navidea Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Navidea Biopharmaceutica and Cardiff Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardiff Oncology are associated (or correlated) with Navidea Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Navidea Biopharmaceutica has no effect on the direction of Cardiff Oncology i.e., Cardiff Oncology and Navidea Biopharmaceutica go up and down completely randomly.
Pair Corralation between Cardiff Oncology and Navidea Biopharmaceutica
Given the investment horizon of 90 days Cardiff Oncology is expected to generate 1.55 times more return on investment than Navidea Biopharmaceutica. However, Cardiff Oncology is 1.55 times more volatile than Navidea Biopharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. Navidea Biopharmaceuticals is currently generating about -0.5 per unit of risk. If you would invest 149.00 in Cardiff Oncology on September 12, 2024 and sell it today you would earn a total of 229.00 from holding Cardiff Oncology or generate 153.69% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 1.14% |
| Values | Daily Returns |
Cardiff Oncology vs. Navidea Biopharmaceuticals
Performance |
| Timeline |
| Cardiff Oncology |
| Navidea Biopharmaceutica |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Cardiff Oncology and Navidea Biopharmaceutica Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cardiff Oncology and Navidea Biopharmaceutica
The main advantage of trading using opposite Cardiff Oncology and Navidea Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardiff Oncology position performs unexpectedly, Navidea Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Navidea Biopharmaceutica will offset losses from the drop in Navidea Biopharmaceutica's long position.| Cardiff Oncology vs. Reviva Pharmaceuticals Holdings | Cardiff Oncology vs. PDS Biotechnology Corp | Cardiff Oncology vs. Reviva Pharmaceuticals Holdings | Cardiff Oncology vs. Eyenovia |
| Navidea Biopharmaceutica vs. NovaBay Pharmaceuticals | Navidea Biopharmaceutica vs. Cyclacel Pharmaceuticals | Navidea Biopharmaceutica vs. Tenax Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |